Diagonal Therapeutics

Diagonal Therapeutics is a biotechnology company that has pioneered a new approach to discovering and developing agonist antibodies. The company's DIAGONAL platform integrates proprietary computational and experimental techniques to overcome historical challenges associated with agonist antibody drug discovery. Diagonal's emerging pipeline (discovered using the DIAGONAL platform) has the potential to provide life-changing therapies to patients by addressing the root causes of diseases.